← Back to Search

Phone-Based Support Sessions for Breast Cancer

N/A
Recruiting
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 years
Awards & highlights
No Placebo-Only Group

Summary

This trial will examine if 3 phone-based sessions can help Latina women with genetic and social risk factors.

Who is the study for?
This trial is for Latina women over 30 years old who have a personal or family history of breast or ovarian cancer and face social challenges affecting their health. They must not have had genetic counseling or testing for cancer, and should be eligible for breast cancer screenings based on guidelines.
What is being tested?
The study tests an empowerment and navigation intervention to help Latinas access breast cancer care. Participants will receive three phone sessions with the study team over consecutive weeks to support them in managing their health risks.
What are the potential side effects?
Since this trial focuses on educational and navigational interventions rather than medical treatments, there are no direct side effects like those associated with drugs or surgeries.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Empower and navigation versus SOC

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Arm 2Experimental Treatment1 Intervention
Standard of Care (SOC)
Group II: Arm 1Experimental Treatment1 Intervention
Empowerment and Navigation

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor
639 Previous Clinical Trials
1,568,554 Total Patients Enrolled
11 Trials studying Breast Cancer
1,341,784 Patients Enrolled for Breast Cancer

Media Library

Empowerment and Navigation Clinical Trial Eligibility Overview. Trial Name: NCT05483283 — N/A
Breast Cancer Research Study Groups: Arm 2, Arm 1
Breast Cancer Clinical Trial 2023: Empowerment and Navigation Highlights & Side Effects. Trial Name: NCT05483283 — N/A
Empowerment and Navigation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05483283 — N/A
~360 spots leftby Sep 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top